{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:20Z","timestamp":1786119260806,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/ede.0b013e31819e3c1a","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:10:09Z","timestamp":1244790609000},"page":"562-568","source":"Crossref","is-referenced-by-count":13,"title":["Targeted BCG Vaccination Against Severe Tuberculosis in Low-prevalence Settings"],"prefix":"10.1097","volume":"20","author":[{"given":"Hester Korthals","family":"Altes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederika","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lugn\u00e8r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cobelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco","family":"Wallinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210207","article-title":"Immunological Basis for Immunization. Module 5: Tuberculosis.","author":"Milstien","year":"1993"},{"key":"R2-15-20210207","first-page":"42","article-title":"Issues Relating to the use of BCG in Immunization Programmes: A Discussion Document.","author":"Fine","year":"1999"},{"key":"R3-15-20210207","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yapd.2006.04.014","article-title":"Tuberculosis in children: an update.","volume":"53","author":"Powell","year":"2006","journal-title":"Adv Pediatr"},{"key":"R4-15-20210207","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(03)14333-4","article-title":"Tuberculosis.","volume":"362","author":"Frieden","year":"2003","journal-title":"Lancet"},{"key":"R5-15-20210207","first-page":"27","article-title":"BCG vaccine. WHO position paper.","volume":"79","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"R6-15-20210207","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2807\/esm.11.03.00604-en","article-title":"European survey of BCG vaccination policies and surveillance in children, 2005.","volume":"11","author":"Infuso","year":"2006","journal-title":"Euro Surveill"},{"key":"R7-15-20210207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/esm.11.03.00603-en","article-title":"Tuberculosis and BCG in Europe.","volume":"11","author":"Watson","year":"2006","journal-title":"Euro Surveill"},{"key":"R8-15-20210207","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2807\/esm.11.03.00606-en","article-title":"Selective BCG vaccination in a country with low incidence of tuberculosis.","volume":"11","author":"Romanus","year":"2006","journal-title":"Euro Surveill"},{"key":"R9-15-20210207","first-page":"22","article-title":"A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guerin in Finland.","volume":"7","author":"Hersh","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"R10-15-20210207","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"R11-15-20210207","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India.","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"R13-15-20210207","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications.","volume":"10","author":"Rubin","year":"1991","journal-title":"Stat Med"},{"key":"R14-15-20210207","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Guerin disease after vaccination: 5case report and review.","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R15-15-20210207","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3201\/eid1305.060865","article-title":"Disseminated bacillus Calmette-Guerin infection and immunodeficiency.","volume":"13","author":"Bernatowska","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R16-15-20210207","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.vaccine.2004.06.019","article-title":"Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.","volume":"23","author":"Welte","year":"2004","journal-title":"Vaccine"},{"key":"R18-15-20210207","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/heapol\/czl018","article-title":"Calculating QALYs, comparing QALY and DALY calculations.","volume":"21","author":"Sassi","year":"2006","journal-title":"Health Policy Plan"},{"key":"R19-15-20210207","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2105\/AJPH.90.8.1241","article-title":"A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group.","volume":"90","author":"Melse","year":"2000","journal-title":"Am J Public Health"},{"key":"R20-15-20210207","first-page":"493","article-title":"Tuberculosis.","author":"Baker","year":"1996"},{"key":"R21-15-20210207","first-page":"541","article-title":"Tuberculosis.","author":"Zuger","year":"1996"},{"key":"R22-15-20210207","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-3156.2003.01185.x","article-title":"Tuberculous meningitis and miliary tuberculosis in young children.","volume":"9","author":"van den Bos","year":"2004","journal-title":"Trop Med Int Health"},{"key":"R23-15-20210207","article-title":"Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020.","year":"1996"},{"key":"R25-15-20210207","first-page":"2075","article-title":"Guidelines and costs [in Dutch].","volume":"142","author":"Casparie","year":"1998","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R26-15-20210207","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.vaccine.2005.12.044","article-title":"Protective effect of Bacillus Calmette-Guerin (BCG) vaccination in children with extra-pulmonary tuberculosis, but not the pulmonary disease. A case-control study in Rosario, Argentina.","volume":"24","author":"Bonifachich","year":"2006","journal-title":"Vaccine"},{"key":"R27-15-20210207","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"R28-15-20210207","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"R29-15-20210207","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"R30-15-20210207","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study.","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/EDE.0b013e31819e3c1a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:03Z","timestamp":1786038903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001648-200907000-00015"}},"subtitle":["Epidemiologic and Economic Assessment"],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0b013e31819e3c1a","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}